Revolution Medicines Inc annual free cash flow for fiscal TTM was -$1.1 billion, a decrease of 17.3% from -$914 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($1.1B) | ($914M) | ($568M) | ($358M) | ($235M) | ($154M) | ($103M) | ($52M) | $0M | ($27M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($356M) | ($276M) | ($211M) | ($229M) | ($198M) | ($140M) | ($134M) | ($131M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RVMD metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All RVMD financial statements → Interactive RVMD charts →
About TickerBase · Data methodology & sources